Oak Bay Biosciences

Website:  www.oakbaybio.com 

Phone: (250) 886 1849

Email: info@oakbaybio.com 

Member Sector: Biopharmaceuticals

Oak Bay Biosciences (OBB) is developing a best-in-class aptamer-based therapeutic for
Stagardt disease, a genetic disease that causes progressive and irreversible blindness.
The molecule has potential to service a serious unmet need and to become a blockbuster
ophthalmology drug.